You have 9 free searches left this month | for more free features.

HIV Protease Inhibitors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV Trial in United States (Ritonavir, Saquinavir, Methadone HCl)

Completed
  • HIV Infections
  • San Francisco, California
  • +6 more
Oct 27, 2021

HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)

Completed
  • HIV Infections
  • +2 more
  • Indinavir sulfate
  • +3 more
  • San Francisco, California
  • +8 more
Oct 28, 2021

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022

HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)

Recruiting
  • HIV-1-infection
  • Multi-Antiviral Resistance
  • REGISTER CREATION
  • Milan, MI, Italy
    Ospedale San Raffaele
Dec 22, 2021

HIV Trial in United States (Pravastatin sodium, Simvastatin, Atorvastatin calcium)

Completed
  • HIV Infections
  • Pravastatin sodium
  • +5 more
  • Los Angeles, California
  • +12 more
Oct 27, 2021

HIV Patients Trial in France (No intervention)

Completed
  • HIV Patients
  • No intervention
  • Créteil, France
  • +5 more
Jul 30, 2021

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

Recruiting
  • HIV I Infection
  • Adiposity
  • Frequently sampled glucose tolerance testing
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 15, 2022

HIV Trial in United States (Fosamprenavir, Lopinavir/Ritonavir, Ritonavir)

Completed
  • HIV Infections
  • Los Angeles, California
  • +12 more
Oct 28, 2021

Protease Inhibitors in Chronic Hepatitis C

Completed
  • Chronic Hepatitis C
    • Graz, Austria
      Department of Internal Medicine, Medical University of Graz
    Jan 11, 2023

    HIV Trial in United States (Lopinavir/Ritonavir, Abacavir sulfate, Nevirapine)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +22 more
    Oct 28, 2021

    HIV, Pregnancy Trial in Worldwide (Lamivudine, Lamivudine/Zidovudine, Nelfinavir mesylate)

    Completed
    • HIV Infections
    • Pregnancy
    • Los Angeles, California
    • +48 more
    Oct 28, 2021

    HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Amprenavir)

    Completed
    • HIV Infections
    • Indinavir sulfate
    • +7 more
    • Los Angeles, California
    • +44 more
    Oct 27, 2021

    HIV Trial in Bangkok (generic single tablet TAF/FTC/DTG)

    Active, not recruiting
    • HIV
    • generic single tablet TAF/FTC/DTG
    • Bangkok, Thailand
    • +1 more
    Mar 22, 2022

    HIV Trial in United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)

    Completed
    • HIV Infections
    • Indinavir sulfate
    • +3 more
    • San Francisco, California
    • +14 more
    Oct 27, 2021

    HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)

    Active, not recruiting
    • HIV-1-infection
    • Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
    • Antwerp, Belgium
    • +28 more
    May 23, 2022

    HIV Trial in United States (Indinavir sulfate, Ritonavir, Amprenavir)

    Completed
    • HIV Infections
    • Indinavir sulfate
    • +5 more
    • Palo Alto, California
    • +7 more
    Oct 28, 2021

    HIV Trial in Puerto Rico, United States (Ritonavir, Nelfinavir mesylate, Nevirapine)

    Completed
    • HIV Infections
    • Birmingham, Alabama
    • +44 more
    Oct 27, 2021

    Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)

    Not yet recruiting
    • Tuberculous Meningitis
    • HIV I Infection
    • Adalimumab Injection
    • Rio De Janeiro, Brazil
    • +2 more
    Jan 31, 2023

    HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

    Recruiting
    • HIV I Infection
    • +2 more
    • Doravirine 100 Mg
    • Los Angeles, California
    • +1 more
    Nov 1, 2022

    HIV Trial in United States (Hydroxyurea, Efavirenz, Stavudine)

    Completed
    • HIV Infections
    • Menlo Park, California
    • +18 more
    Oct 27, 2021

    HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

    Recruiting
    • HIV/AIDS
    • Antwerp, Belgium
    • +47 more
    Jan 9, 2023

    Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

    Not yet recruiting
    • Metabolic Effects
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Gut Microbiota, PGx and INSTIs Response

    Recruiting
    • HIV Infections
    • Brussels, Belgium
      Cliniques universitaires Saint-Luc
    Jan 16, 2023